| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 227.675 | 85 |
| GSM780708 | Untreated after 4 days (C2_1) | 244.706 | 86 |
| GSM780709 | Untreated after 4 days (C3_1) | 312.444 | 88 |
| GSM780719 | Untreated after 4 days (C1_2) | 229.605 | 85 |
| GSM780720 | Untreated after 4 days (C2_2) | 234.871 | 85 |
| GSM780721 | Untreated after 4 days (C3_2) | 348.294 | 89 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 230.337 | 85 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 221.463 | 85 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 164.77 | 81 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 203.237 | 84 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 249.958 | 86 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 163.266 | 81 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 282.477 | 87 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 225.947 | 85 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 261.034 | 86 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 259.571 | 86 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 203.51 | 84 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 236.298 | 85 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 200.162 | 84 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 213.023 | 84 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 198.062 | 83 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 200.787 | 84 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 216.004 | 84 |